Literature DB >> 21123041

New developments in the induction and antiviral effectors of type I interferon.

Su-Yang Liu1, David Jesse Sanchez, Genhong Cheng.   

Abstract

Type I interferons (IFNs) are cytokines of the innate immune system that induce antiviral protein expression in response to viral infection. Various proteins and pathways have been shown to recognize nucleic acid ligands especially from RNA viruses. Here, we will review recent developments including transcription of DNA virus genomes into RNA ligands, and the recognition of viruses by TLR2 for interferon induction. The induced IFNs activate many interferon stimulated genes (ISGs) that have direct antiviral effects. Recent studies have identified IFITM proteins as the first ISG to inhibit viral entry processes and revealed mechanistic understanding of known antiviral ISGs such as ISG15 and Viperin.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123041      PMCID: PMC3822007          DOI: 10.1016/j.coi.2010.11.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  59 in total

1.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells.

Authors:  Chen Zhao; Tien-Ying Hsiang; Rei-Lin Kuo; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

3.  APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

Authors:  Jean L Mbisa; Wei Bu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Structural characterization reveals that viperin is a radical S-adenosyl-L-methionine (SAM) enzyme.

Authors:  Goyal Shaveta; Jiahai Shi; Vincent T K Chow; Jianxing Song
Journal:  Biochem Biophys Res Commun       Date:  2009-12-22       Impact factor: 3.575

Review 5.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

6.  Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells.

Authors:  Tien-Ying Hsiang; Chen Zhao; Robert M Krug
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

7.  Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.

Authors:  Ren-Jye Lin; Han-Pang Yu; Bi-Lan Chang; Wei-Chun Tang; Ching-Len Liao; Yi-Ling Lin
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands.

Authors:  Roman Barbalat; Laura Lau; Richard M Locksley; Gregory M Barton
Journal:  Nat Immunol       Date:  2009-10-04       Impact factor: 25.606

9.  The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Authors:  Abraham L Brass; I-Chueh Huang; Yair Benita; Sinu P John; Manoj N Krishnan; Eric M Feeley; Bethany J Ryan; Jessica L Weyer; Louise van der Weyden; Erol Fikrig; David J Adams; Ramnik J Xavier; Michael Farzan; Stephen J Elledge
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

10.  Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.

Authors:  Yasuhiro Itsui; Naoya Sakamoto; Sei Kakinuma; Mina Nakagawa; Yuko Sekine-Osajima; Megumi Tasaka-Fujita; Yuki Nishimura-Sakurai; Gouki Suda; Yuko Karakama; Kako Mishima; Machi Yamamoto; Takako Watanabe; Mayumi Ueyama; Yusuke Funaoka; Seishin Azuma; Mamoru Watanabe
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

View more
  86 in total

1.  S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Authors:  Jacob S Yount; Roos A Karssemeijer; Howard C Hang
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

2.  New PARP gene with an anti-alphavirus function.

Authors:  Svetlana Atasheva; Maryna Akhrymuk; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.

Authors:  Suwan Sinha; Yuhong Guo; Suwannee Thet; Dorothy Yuan
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

Review 4.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

5.  Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory Neurons.

Authors:  Sarah Katzenell; David A Leib
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

Authors:  Kristy J Szretter; James D Brien; Larissa B Thackray; Herbert W Virgin; Peter Cresswell; Michael S Diamond
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a.

Authors:  Yu-Jin Lee; Xiaozhen Zhang; Estefania Vazquez; Gayathri Shivasabesan; Howard A Young; Alison Murphy; Honghui Wang; Anthony F Suffredini; Ulrich Siebenlist; Shyam Kottilil
Journal:  J Interferon Cytokine Res       Date:  2013-10-30       Impact factor: 2.607

8.  RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi.

Authors:  Xiaoxu Fan; Shuwei Dong; Yang Li; Shou-wei Ding; Ming Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-04-03       Impact factor: 3.575

9.  Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.

Authors:  Junji Xing; Leiyun Weng; Bin Yuan; Zhuo Wang; Li Jia; Rui Jin; Hongbo Lu; Xian Chang Li; Yong-Jun Liu; Zhiqiang Zhang
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

10.  Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses.

Authors:  Wanwan Huai; Hui Song; Zhongxia Yu; Wenwen Wang; Lihui Han; Takeharu Sakamoto; Motoharu Seiki; Lining Zhang; Qunye Zhang; Wei Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.